top of page

iPROLEPSIS: PSORIATIC ARTHRITIS INFLAMMATION EXPLAINED THROUGH MULTI-SOURCE DATA ANALYSIS GUIDING A NOVEL PERSONALISED DIGITAL CARE ECOSYSTEM

 

Psoriatic Arthritis (PsA) is a chronic, progressive, inflammatory disease affecting 1-2% of the general population, while manifesting in up to 30% of people with psoriasis (PsO).

iPROLEPSIS is a HorizonEurope-funded project developing a novel personalised digital care ecosystem for people with PsA.

 iPROLEPSIS OBJECTIVES:

iPROLEPSIS consortium works on 7 ambitious key objectives in the field of 

Psoriatic Arthritis (PsA): 

database1.png

Discover PsA inflammation drivers through AI-driven health, environmental and omics data mining

digital1.png

Develop and validate objective digital biomarkers for tracking inflammatory symptoms and disease activity

cell1.png

Investigate the role of mast cells and features from non-invasive skin microvascular/joint imaging in inflammatory symptoms tracking

medical1.png

Build trustworthy AI models for personalised PsA risk prediction, early diagnosis and high disease activity prognosis

hand1.png

Develop ICT-based personalised interventions to sustain or even improve quality-of-life

patient1.png

Develop and clinically validate the iPROLEPSIS digital health ecosystem to empower persons with/at risk of PsA and healthcare professionals

group1.png

Co-create the iPROLEPSIS ecosystem with key stakeholders, following ethical, inclusive and trustworthy AI principles

Subscribe to Our Newsletter

Thanks for submitting!

bottom of page